topiramate sold brand name topamax among others medication used treat epilepsy prevent also used alcohol dependence essential epilepsy includes treatment generalized focal taken orally common side effects include tingling feeling tired loss appetite abdominal pain weight decreased cognitive function trouble serious side effects may include suicide increased ammonia levels resulting encephalopathy kidney use pregnancy may result harm baby use breastfeeding mechanism action topiramate approved medical use united states available generic commonly prescribed medication united states million topiramate used treat epilepsy children adults originally used children indicated treatment lennoxgastaut syndrome disorder causes seizures developmental delay frequently prescribed prevention decreases frequency topiramate used treat medication overuse headache recommended european federation neurological societies one medications showing effectiveness review found topiramate use chronic low back topiramate shown work pain medicine diabetic neuropathy neuropathic condition adequately one common offlabel use topiramate treatment bipolar review published suggested benefit topiramate treatment symptoms borderline personality disorder however authors noted based one randomized controlled trial requires topiramate used treatment us veterans affairs department defense guidelines substance use disorders list topiramate strong recommendations alcohol use uses include treatment binge eating offsetting weight gain induced taking antipsychotic combination phenterminetopiramate approved united states weight loss studied potential treatment post traumatic stress evidence use topiramate management cravings related withdrawal people taking topiramate aware following risks adverse effects common incidence adverse effects include common incidence adverse effects include rarely inhibition carbonic anhydrase may strong enough cause metabolic acidosis clinical us food drug administration fda notified prescribers topiramate cause acute myopia secondary angle closure glaucoma small subset people take topiramate symptoms typically begin first month use include blurred vision eye pain discontinuation topiramate may halt progression ocular damage may reverse visual impairment preliminary data suggests several antiepileptic drugs topiramate carries increased risk congenital might particularly important women take topiramate prevent migraine attacks march fda notified healthcare professionals patients increased risk development cleft lip andor cleft palate oral clefts infants born women treated topamax topiramate pregnancy placed pregnancy category cognitive wordfinding difficulties may occur patients may respond topiramate associated statistically significant increase suicidal thoughts actions listed one possible side effects drug small number people symptoms acute acute chronic exposure topiramate range asymptomatic status epilepticus including patients seizure children overdose may also result topiramate deemed primary substance led fatal overdoses cases complicated polydrug common signs overdose dilated pupils somnolence dizziness psychomotor agitation abnormal uncoordinated body symptoms overdose may include limited tocitation needed specific antidote available treatment entirely supportive topiramate many drugdrug interactions common listed topiramate molecule sulfamate modified sugar specifically fructose diacetonide unusual chemical structure pharmaceutical topiramate quickly absorbed oral use half life hours steady state drug reached days patients normal renal drug excreted urine unchanged remainder extensively metabolized hydroxylation hydrolysis glucuronidation six metabolites identified humans none constitutes administered dose several cellular targets proposed relevant therapeutic activity include voltagegated sodium channels highvoltageactivated calcium channels gabaa receptors ampakainate receptors carbonic anhydrase isoenzymes evidence topiramate may alter activity targets modifying phosphorylation state instead direct effect sodium channels could particular relevance seizure protection although topiramate inhibit highvoltageactivated calcium channels relevance clinical activity uncertain effects specific gabaa receptor isoforms could also contribute antiseizure activity drug topiramate selectively inhibits cytosolic type ii membrane associated type iv forms carbonic anhydrase action carbonic anhydrase isoenzymes may contribute drugs sideeffects including propensity cause metabolic acidosis calcium phosphate kidney stones topiramate inhibits maximal seizure activity electroconvulsive therapy pentylenetetrazolinduced seizures well partial secondarily generalized tonicclonic seizures kindling model findings predictive broad spectrum activities clinically action mitochondrial permeability transition pores proposed many anticonvulsants associated apoptosis young animals animal experiments found topiramate one anticonvulsants see levetiracetam carbamazepine lamotrigine induce apoptosis young animals doses needed produce anticonvulsant blood serum plasma topiramate concentrations may measured using immunoassay chromatographic methods monitor therapy confirm diagnosis poisoning hospitalized patients assist medicolegal death investigation plasma levels usually less mgl therapeutic administration range mgl overdose topiramate discovered bruce e maryanoff joseph f gardocki research work mcneil topiramate first sold mylan pharmaceuticals granted final approval fda sale generic topiramate united states generic version made available september last patent topiramate us use children expired february systematic review seizure treatment infants aged months identified three studies evaluated use topiramate though adverse effects including upper respiratory tract infection loss appetite rarely severe enough medication discontinued age group effectiveness reducing seizures inconclusive available research suffers small sample sizes inconsistent findings inadequate comparison media related topiramate wikimedia commons httpsenwikipediaorgwikitopiramate